{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:25:13Z","timestamp":1778883913750,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jneuroim.2016.11.010","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T16:46:47Z","timestamp":1480697207000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The clinical characteristics of AQP4 antibody positive NMO\/SD in a large cohort of Chinese Han patients"],"prefix":"10.1016","volume":"302","author":[{"given":"Jingzi","family":"ZhangBao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongjia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanzhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jneuroim.2016.11.010_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1352458509353651","article-title":"Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics","volume":"16","author":"Adoni","year":"2010","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.jneuroim.2016.11.010_bb0010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00415-010-5780-4","article-title":"Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients","volume":"258","author":"Akman-Demir","year":"2011","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2016.11.010_bb0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrneurol.2014.129","article-title":"Pain in neuromyelitis optica\u2014prevalence, pathogenesis and therapy","volume":"10","author":"Bradl","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.jneuroim.2016.11.010_bb0020","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/1352458509104585","article-title":"Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies","volume":"15","author":"Cabrera-G\u00f3mez","year":"2009","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.jneuroim.2016.11.010_bb0025","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3181d31e35","article-title":"Neuromyelitis optica in France a multicenter study of 125 patients","volume":"74","author":"Collongues","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.11.010_bb0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clineuro.2015.04.001","article-title":"Neuromyelitis optica in Portugal (NEMIPORT) \u2013 a multicentre study","volume":"134","author":"Domingos","year":"2015","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.jneuroim.2016.11.010_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2016.11.010_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"Pt 6","key":"10.1016\/j.jneuroim.2016.11.010_bb0045","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"issue":"9451","key":"10.1016\/j.jneuroim.2016.11.010_bb0050","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jneuroim.2016.11.010_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.58.1.70","article-title":"Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies","volume":"58","author":"Morrissey","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.jneuroim.2016.11.010_bb0060","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/jnnp-2011-300403","article-title":"Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes","volume":"82","author":"Nagaishi","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.jneuroim.2016.11.010_bb0065","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/jnnp.2005.080390","article-title":"Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG","volume":"77","author":"Nakashima","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.jneuroim.2016.11.010_bb0070","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1468-1331.2009.02928.x","article-title":"Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients","volume":"17","author":"Sahraian","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2016.11.010_bb0075","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000225","article-title":"Neuromyelitis optica spectrum disorders comparison according to the phenotype and serostatus","volume":"3","author":"Sep\u00falveda","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.jneuroim.2016.11.010_bb0080","first-page":"455","article-title":"Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines","volume":"27","author":"Simon","year":"2006","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.jneuroim.2016.11.010_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2016.11.010_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jneuroim.2016.11.010_bb0095","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.jneuroim.2016.11.010_bb0100","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jneuroim.2016.11.010_bb0105","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1177\/1352458514522103","article-title":"Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life","volume":"20","author":"Zhao","year":"2014","journal-title":"Mult. Scler."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816302028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816302028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:28:33Z","timestamp":1759048113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816302028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":21,"alternative-id":["S0165572816302028"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.11.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical characteristics of AQP4 antibody positive NMO\/SD in a large cohort of Chinese Han patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}